Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shares shot up 5.7% during trading on Wednesday . The stock traded as high as $55.80 and last traded at $54.45. 190,977 shares traded hands during trading, a decline of 29% from the average session volume of 268,220 shares. The stock had previously closed at $51.50.
Analyst Upgrades and Downgrades
Several research firms have recently commented on ZEPP. Weiss Ratings restated a "sell (d-)" rating on shares of Zepp Health in a research report on Wednesday, October 8th. Fundamental Research set a $60.23 price target on Zepp Health and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Finally, Wall Street Zen upgraded Zepp Health to a "hold" rating in a research report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $60.23.
View Our Latest Stock Analysis on Zepp Health
Zepp Health Stock Up 5.7%
The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10. The company has a market cap of $789.54 million, a price-to-earnings ratio of -11.27 and a beta of 1.32. The business has a 50-day simple moving average of $45.31 and a 200-day simple moving average of $18.86.
About Zepp Health
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.